Tempus Soars 11% on Record $1.31 Billion Volume Surge Ranks 72nd in Active Stocks as AI Healthcare Expansion Fuels Institutional Interest

On October 8, 2025, Tempus (TEM) surged 11.01% to close trading, with a daily trading volume of $1.31 billion, marking a 90.52% increase from the prior day and ranking 72nd among active stocks. The sharp volume spike and price rally suggest renewed institutional or retail interest in the AI-driven healthcare analytics firm.

Recent developments indicate Tempus is expanding its clinical data partnerships with three major U.S. hospital networks to enhance AI diagnostic tools. This collaboration, announced via a regulatory filing, aims to integrate real-time patient data into its predictive analytics models, potentially accelerating revenue growth in the healthcare AI sector. Analysts note that broader data access could strengthen Tempus' competitive edge over peers in the nascent AI healthcare market.

The stock's performance aligns with positive momentum in AI healthcare stocks following a Federal Trade Commission ruling that eased antitrust restrictions on data-sharing partnerships between tech firms and medical institutions. While the ruling applies broadly, its impact on Tempus is amplified by its recent strategic moves to secure data sources critical for training its AI algorithms.

To execute this back-test accurately, the following parameters require confirmation: the market universe (e.g., U.S. listed stocks), volume measurement criteria (shares vs. dollar value), rebalancing frequency, trade execution timing (close-to-close vs. open-to-close), position weighting method (equal-weight vs. volume-weighted), and whether transaction costs will be included. Once these details are finalized, the strategy can be back-tested from January 3, 2022, to the current date using daily rebalancing signals.